Pay-for-performance in disease management: A systematic review of the literature

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  De Bruin, Simone R ^a   Baan, Caroline A ^a   Struijs, Jeroen N ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MANAGEMENT; ECONOMICS; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; LONG TERM CARE; REIMBURSEMENT; REVIEW; STANDARD; STATISTICS;

DISEASE MANAGEMENT; HEALTH CARE COSTS; HUMANS; LONG-TERM CARE; QUALITY OF HEALTH CARE; REIMBURSEMENT, INCENTIVE;

EID: 80053962865     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-272     Document Type: Article

References (46)

1. The global burden of disease, 2004 update. World Health Organization, http://www.who.int/healthinfo/global-burden-disease/GBD-report-2004update-full. pdf Retrieved 21 December 2009 from
2. Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. Marengoni A, Winblad B, Karp A, Fratiglioni L, American Journal of Public Health 2008 98 7 1198 1200 10.2105/AJPH.2007.121137 18511722 (Pubitemid 351947989)
3. Preventing chronic diseases: a vital investment. World Health Organization, http://whqlibdoc.who.int/publications/2005/9241563001-eng.pdf Retrieved 21 December 2009 from
4. Co-ordination and management of chronic conditions in Europe: The role of primary care-Position paper of the European forum for primary care. Gre S, Baan CA, Clanan M, Dedeu T, Groenewegen P, Howson H, Maroy L, Nolte E, Redaèlli M, Saarelma O, et al. Quality in Primary Care 2009 17 1 75 86 19281678
5. Finding common ground: patient-centeredness and evidence-based chronic illness care. Wagner EH, Bennett SM, Austin BT, Greene SM, Schaefer JK, Vonkorff M, Journal of Alternative and Complementary Medicine 2005 11 Suppl 1 7 15
6. Evidence for the effect of disease management: is $1 billion a year a good investment? Mattke S, Seid M, Ma S, American Journal of Managed Care 2007 13 12 670 676 18069910 (Pubitemid 350294568)
7. Improving chronic illness care: translating evidence into action. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A, Health Affairs (Millwood) 2001 20 6 64 78 10.1377/hlthaff.20.6.64 (Pubitemid 33707442)
8. How can chronic disease management programmes operate across care settings and providers? Singh D, Birmingham: World Health Organization 2008
9. Impact of disease management programs on healthcare expenditures for patients with diabetes, depression, heart failure or chronic obstructive pulmonary disease: a systematic review of the literature. De Bruin SR, Heijink R, Lemmens L, Struijs JN, Baan CA, Health Policy 2011 101 2 105 121 10.1016/j.healthpol.2011.03.006 21592607
10. Quality-based financial incentives in health care: can we improve quality by paying for it? Conrad DA, Perry L, Annual Review of Public Health 2009 30 357 371 10.1146/annurev.publhealth.031308.100243 19296779
11. Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issues. Chaix-Couturier C, Durand-Zaleski I, Jolly D, Durieux P, International Journal for Quality in Health Care 2000 12 2 133 142 10.1093/intqhc/12.2.133 10830670 (Pubitemid 30262229)
12. Paying for quality: providers' incentives for quality improvement. Rosenthal MB, Fernandopulle R, Song HR, Landon B, Health Affairs (Millwood) 2004 23 2 127 141 10.1377/hlthaff.23.2.127 (Pubitemid 38471049)
13. Chronic care management: how to best deal with the variation in its effectiveness? Drewes H, Vrijhoef B, Elissen A, Lemmens K, Lemmens L, Meeuwissen J, Steuten LM, Meijboom B, Westert G, Baan CA, (submitted)
14. Chronic care management for patients with COPD: A critical review of available evidence. Lemmens K, Lemmens L, Boom J, Drewes H, Meeuwissen J, Steuten L, Vrijhoef H, Baan CA, Accepted for publication by Journal of Evaluation in Clinical Practice
15. The role of patient care teams in chronic disease management. Wagner EH, British Medical Journal 2000 320 7234 569 572 10.1136/bmj.320.7234.569 10688568 (Pubitemid 30175806)
16. Putting smart money to work for quality improvement. Beaulieu ND, Horrigan DR, Health Services Research 2005 40 5 Pt 1 1318 1334 16174136 (Pubitemid 41442441)
17. The Performance Based Incentive Program (PBIP): A Model for Quality Improvement and Cost. BlueCross BlueShield Association, http://www.bcbs.com/ innovations/ Retrieved 28 February 2011 from
18. Impact of pay-for-performance contracts and network registry on diabetes and asthma HEDIS measures in an integrated delivery network. Levin-Scherz J, DeVita N, Timbie J, Medical Care Research and Review 2006 63 1 Suppl 14S 28S 10.1177/1077558705284057 16688922
19. Merging P4P and disease management: how do you know which one is working? Smith AL, Journal of Managed Care Pharmacy 2007 13 2 Suppl B 7 10 17955623
20. Guidelines and performance measures for diabetes. Ahmann AJ, American Journal of Managed Care 2007 13 Suppl 2 41 46 17417932
21. Quality incentive payment systems: promise and problems. Bonis PA, Journal of Clinical Gastroenterology 2005 39 4 Suppl 2 176 182 15758655
22. Bridges to Excellence. Health Care Incentives Improvement Institute, http://www.bridgestoexcellence.org/ Retrieved 28 February 2011 from
23. Aligning incentives in bridges to excellence. Anonymous, Managed Care Interface 2004 Suppl 5 6 13
24. CA health plans collaborate in 'pay for performance' program to boost chronic care management. Anonymous, Disease Management Advisor 2002 8 4 54 58 49 11995434
25. The medical group pay-for-performance initiative in California and diabetes care. Berenbeim D, Managed Care Interface 2003 Suppl C 3 4 14569628
26. Evaluation of the relationship between a chronic disease care management program and California pay-for-performance diabetes care cholesterol measures in one medical group. Cutler TW, Palmieri J, Khalsa M, Stebbins M, Journal of Managed Care Pharmacy 2007 13 7 578 588 17874864 (Pubitemid 47610392)
27. Integrated Healthcare Association (IHA), Pay for Performance (P4P) Program. Overview. Integrated Healthcare Association, http://www.iha.org/pdfs- documents/p4p-california/P4PFactSheet-July2010.pdf Retrieved 28 February 2011 from
28. Integrated Healthcare Association Pay for Performance (P4P) Program, Program Results. Integrated Healthcare Association, http://www.iha.org/program- results.html Retrieved 28 February 2011 from
29. Integrated Healthcare Association Pay for Performance (P4P) Program, Awards. Integrated Healthcare Association, http://www.iha.org/p4p-awards.html Retrieved 28 February 2011 from
30. Relationship between quality improvement processes and clinical performance. Damberg CL, Shortell SM, Raube K, Gillies RR, Rittenhouse D, McCurdy RK, Casalino LP, Adams J, American Journal of Managed Care 2010 16 8 601 606 20712393
31. Paying for performance: implementing a statewide project in California. Damberg CL, Raube K, Williams T, Shortell SM, Quality Management in Health Care 2005 14 2 66 79 15907016
32. Medicare physician group practice demonstration design: quality and efficiency pay-for-performance. Kautter J, Pope GC, Trisolini M, Grund S, Health Care Financing Review 2007 29 1 15 29 18624077 (Pubitemid 350261903)
33. The Medicare Physician Group Practice Demonstration: lessons learned on improving quality and efficiency in healthcare. Trisolini M, Aggarwal J, Leung M, Pope GC, Kautter J, The Commonwealth Fund 2008
34. Financial incentives for disease management programmes and integrated care in German social health insurance. Gre S, Focke A, Hessel F, Wasem J, Health Policy 2006 78 2-3 295 305 10.1016/j.healthpol.2005.11.011 16343688 (Pubitemid 44247218)
35. Practice Incentives Program (PIP) payments and calculations. Australian Government. Medicare Australia, http://www.medicareaustralia.gov.au/provider/ incentives/pip/payment-formula/index.jsp Retrieved 28 February 2011 from
36. Practice Incentives Program (PIP). Australian Government. Medicare Australia, http://www.medicareaustralia.gov.au/provider/incentives/pip/index.jsp Retrieved 28 February 2011 from
37. Diabetes 'cycles of care' in general practice-do government incentives help? Saunders M, Schattner P, Mathews M, Australian Family Physician 2008 37 9 781 784 18797538
38. The effects of an incentive program on quality of care in diabetes management. Scott A, Schurer S, Jensen PH, Sivey P, Health Economics 2009 18 9 1091 1108 10.1002/hec.1536 19644938
39. External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases. Casalino L, Gillies RR, Shortell SM, Schmittdiel JA, Bodenheimer T, Robinson JC, Rundall T, Oswald N, Schauffler H, Wang MC, JAMA 2003 289 4 434 441 10.1001/jama.289.4.434 12533122 (Pubitemid 36119963)
40. Will financial incentives and penalties improve hospital care? Maynard A, Bloor K, British Medical Journal 2010 340 88 10.1136/bmj.c88 20093280
41. Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study. Serumaga B, Ross-Degnan D, Avery AJ, Elliott RA, Majumdar SR, Zhang F, Soumerai SB, British Medical Journal 2011 342 108 10.1136/bmj.d108 21266440
42. Early experience with pay-for-performance: from concept to practice. Rosenthal MB, Frank RG, Li Z, Epstein AM, JAMA 2005 294 14 1788 1793 10.1001/jama.294.14.1788 16219882 (Pubitemid 41434625)
43. Systematic review: Effects, design choices, and context of pay-for-performance in health care. Van Herck P, De Smedt D, Annemans L, Remmen R, Rosenthal MB, Sermeus W, BMC Health Services Research 2010 10 247 10.1186/1472-6963-10-247 20731816
44. Lessons from evaluations of purchaser pay-for-performance programs. Christianson J, Leatherman S, Sutherland K, Medical Care Research and Review 2008 65 6 5S 35S 10.1177/1077558708324236 19015377
45. Pay-for-performance. Will the latest payment trend improve care? Rosenthal MB, Dudley RA, JAMA 2007 297 7 740 743 10.1001/jama.297.7.740 17312294 (Pubitemid 46294563)
46. Effect of financial incentives on inequalities in the delivery of primary clinical care in England: analysis of clinical activity indicators for the quality and outcomes framework. Doran T, Fullwood C, Kontopantelis E, Reeves D, Lancet 2008 372 9640 728 736 10.1016/S0140-6736(08)61123-X 18701159